bf/NASDAQ:TGTX_icon.jpeg

COM:TGTHERAPEUTICS

TG Therapeutics Inc

  • Stock

Last Close

34.55

22/11 21:00

Market Cap

3.17B

Beta: -

Volume Today

2.57M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-20.48M
-
-55.78M
172.39%
-62.95M
12.85%
-78.25M
24.31%
-118.48M
51.40%
-173.48M
46.43%
-172.87M
0.35%
-279.38M
61.61%
-348.10M
24.60%
-198.34M
43.02%
12.67M
106.39%
depreciation and amortization
1.13K
-
3.93K
248.80%
15.45K
293.08%
62.96K
307.46%
82.36K
30.81%
88K
6.85%
282K
220.45%
374K
32.62%
494K
32.09%
515K
4.25%
423K
17.86%
deferred income tax
10.01M
-
10.01M
0%
5.84B
58,198.62%
5.84B
0%
61.32K
100.00%
-119K
294.06%
-257K
115.97%
-30K
88.33%
517K
1,823.33%
-126.62M
-
stock based compensation
5.20M
-
21.11M
305.63%
15.70M
25.62%
7.51M
52.16%
15.95M
112.32%
12.89M
19.19%
11.34M
12.04%
80.29M
608.33%
61.27M
23.68%
19.18M
68.69%
37.93M
97.72%
change in working capital
4.07M
-
-6.05M
248.73%
2.07M
134.17%
8.77M
324.50%
8.56M
2.36%
27.76M
224.15%
25.19M
9.27%
-19.76M
178.43%
-12.22M
38.17%
-1.65M
86.52%
-84.66M
5,040.19%
accounts receivables
-11K
-
-6K
45.45%
-1.39M
23,050%
1.39M
200%
-51.09M
3,778.40%
inventory
11K
-
6K
45.45%
-15.99M
266,616.67%
-36.94M
-
accounts payables
4.03M
-
-603.38K
114.96%
5.47M
1,006.72%
6.49M
18.68%
-4.79M
-
11.63M
342.57%
15.99M
37.49%
-11.01M
168.85%
192K
101.74%
other working capital
31.09K
-
-5.44M
17,606.82%
-3.40M
37.46%
2.28M
166.95%
8.56M
275.77%
27.76M
224.15%
29.98M
8.00%
-31.39M
204.68%
-10.83M
65.51%
7.97M
173.65%
3.18M
60.12%
other non cash items
-9.63M
-
-4.35M
54.79%
-5.84B
133,975.49%
-5.84B
0.00%
58.74K
100.00%
3.94M
6,605.94%
3.52M
10.76%
4.00M
13.74%
2.40M
40.02%
4.11M
71.48%
128.84M
3,033.17%
net cash provided by operating activities
-10.82M
-
-35.06M
223.90%
-44.69M
27.47%
-61.59M
37.82%
-93.76M
52.24%
-128.93M
37.50%
-132.81M
3.01%
-214.51M
61.52%
-295.63M
37.82%
-176.17M
40.41%
-31.41M
82.17%
investments in property plant and equipment
-5.68K
-
-18.57K
226.88%
-42.22K
127.34%
-343.99K
714.80%
-2.23K
99.35%
-90K
3,941.31%
-131K
45.56%
-357K
172.52%
-401K
12.32%
-14K
96.51%
acquisitions net
587K
-
24.15M
4,014.65%
-69K
100.29%
20.00M
29,084.06%
purchases of investments
-4.92M
-
-18.34M
272.71%
-48.99M
167.19%
-15.20M
68.98%
-28.01M
84.25%
-31.23M
11.51%
-29.84M
4.46%
-67.40M
125.90%
-55.53M
17.61%
-107.27M
93.18%
-146.88M
36.92%
sales maturities of investments
24.35M
-
42.09M
72.85%
19.80M
52.96%
32.50M
64.14%
29.25M
10%
43.25M
47.86%
55.60M
28.55%
87.28M
56.97%
96.23M
10.26%
other investing activites
-587K
-
-24.15M
4,014.65%
69K
100.29%
-20.00M
29,084.06%
net cash used for investing activites
-4.93M
-
-18.36M
272.65%
-24.69M
34.49%
26.55M
207.53%
-8.21M
130.92%
1.18M
114.38%
-718K
160.85%
-24.51M
3,313.65%
-332K
98.65%
-20.01M
5,928.01%
-50.65M
153.09%
debt repayment
-677.78K
-
-29.19M
-
-30M
-
-975K
96.75%
-24.88M
2,451.28%
common stock issued
37.65M
-
65.61M
74.28%
67.76M
3.27%
4.41M
93.49%
131.52M
2,881.38%
113.64M
13.59%
175.02M
54.01%
679.68M
288.34%
2.22M
99.67%
584K
73.68%
47.83M
8,090.07%
common stock repurchased
-149.80K
-
dividends paid
other financing activites
2.28M
-
3.71M
62.53%
963.17K
74.02%
604.74K
37.21%
2.14M
254.38%
58.38M
-
147K
99.75%
69.20M
46,974.83%
49.75M
-
net cash used provided by financing activities
39.78M
-
68.64M
72.56%
68.72M
0.12%
5.02M
92.70%
133.66M
2,564.66%
113.64M
14.98%
204.21M
79.70%
679.83M
232.90%
41.42M
93.91%
-391K
100.94%
72.70M
18,694.63%
effect of forex changes on cash
-66.87M
-
net change in cash
24.03M
-
15.23M
36.63%
-652.46K
104.28%
-30.03M
4,502.62%
31.69M
205.52%
-14.11M
144.52%
70.69M
601.13%
440.81M
523.59%
-254.55M
157.75%
-196.57M
22.77%
-9.37M
95.23%
cash at beginning of period
16.46M
-
40.49M
146.02%
55.71M
37.61%
55.06M
1.17%
25.03M
54.54%
57.30M
128.93%
43.20M
24.62%
113.89M
163.64%
554.70M
387.06%
300.15M
45.89%
102.30M
65.92%
cash at end of period
40.49M
-
55.71M
37.61%
55.06M
1.17%
25.03M
54.54%
56.72M
126.59%
43.20M
23.84%
113.89M
163.64%
554.70M
387.06%
300.15M
45.89%
103.58M
65.49%
92.93M
10.28%
operating cash flow
-10.82M
-
-35.06M
223.90%
-44.69M
27.47%
-61.59M
37.82%
-93.76M
52.24%
-128.93M
37.50%
-132.81M
3.01%
-214.51M
61.52%
-295.63M
37.82%
-176.17M
40.41%
-31.41M
82.17%
capital expenditure
-5.68K
-
-18.57K
226.88%
-42.22K
127.34%
-343.99K
714.80%
-2.23K
99.35%
-90K
3,941.31%
-131K
45.56%
-357K
172.52%
-401K
12.32%
-14K
96.51%
free cash flow
-10.83M
-
-35.08M
223.90%
-44.73M
27.52%
-61.94M
38.46%
-93.77M
51.39%
-129.01M
37.59%
-132.94M
3.04%
-214.86M
61.63%
-296.04M
37.78%
-176.18M
40.49%
-31.41M
82.17%

All numbers in (except ratios and percentages)